Back to Index

  • Rivers Trial Original
  • Rivers Trial

    "Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock". The New England Journal of Medicine. 2001. 345(19):1368-1377. PubMed • Full text • PDF

    Contents


    1 Clinical Question
    2 Bottom Line
    3 Major Points
    4 Guidelines
    5 Design
    6 Population
    6.1 Inclusion Criteria
    6.2 Exclusion Criteria
    6.3 Baseline Characteristics
    7 Interventions
    8 Outcomes
    8.1 Primary Outcome
    8.2 Secondary Outcomes
    9 Criticisms
    10 Funding
    11 Further Reading

    Clinical Question


    Does early goal-directed therapy before admission to the intensive care unit improve the outcomes of patients with severe sepsis and septic shock?

    Bottom Line


    Early goal-directed therapy in patients with severe sepsis and septic shock reduced in-hospital mortality compared to standard therapy.

    Major Points


    Early goal-directed therapy aims to optimize cardiac preload, afterload, and contractility to balance oxygen delivery with oxygen demand. This study assessed the efficacy of implementing early goal-directed therapy before admission to the intensive care unit (ICU) in patients with severe sepsis or septic shock.

    Guidelines


    Current guidelines recommend early goal-directed therapy as part of the initial management for severe sepsis and septic shock.

    Design


    - Prospective, randomized, controlled trial
    - N=263 patients with severe sepsis or septic shock
    - Early goal-directed therapy (n=130) vs. Standard therapy (n=133)
    - Setting: Urban emergency department
    - Enrollment: March 1997 to March 2000

    Population


    Inclusion Criteria
    - Adults with severe sepsis, septic shock, or sepsis syndrome presenting to the emergency department
    - Two of four criteria for systemic inflammatory response syndrome met
    - Systolic blood pressure ≤90 mm Hg or blood lactate concentration ≥4 mmol per liter

    Exclusion Criteria
    - Age <18, pregnancy, acute cerebral vascular event, acute coronary syndrome, immediate surgical requirement, and other specific conditions

    Baseline Characteristics
    - No significant differences between the two groups

    Interventions


    - Early goal-directed therapy or standard therapy conducted for at least six hours pre-ICU
    - Central venous catheter capable of measuring central venous oxygen saturation was used for early goal-directed therapy
    - Standard therapy group received critical-care consultation and care based on clinician discretion

    Outcomes


    Primary Outcome
    - In-hospital mortality: 30.5% in early goal-directed therapy vs. 46.5% in standard therapy (P=0.009)

    Secondary Outcomes
    - Early goal-directed therapy group had higher central venous oxygen saturation, lower lactate concentration, lower base deficit, and higher pH than standard therapy group (P≤0.02 for all)
    - Lower mean APACHE II scores, indicating less severe organ dysfunction, in early goal-directed therapy group (P<0.001)

    Criticisms


    - The trial may have inherent bias from the influence of investigators on the care provided to the early goal-directed therapy group

    Funding


    - Funded by Henry Ford Health Systems Fund for Research, a Weatherby Healthcare Resuscitation Fellowship, equipment from Edwards Lifesciences, and laboratory assays equipment from Nova Biomedical

    Further Reading


    - Full text of the study available in The New England Journal of Medicine